SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin submits press note

03 Jan 2020 Evaluate

Lupin has informed about submission of a press note as regards the Company's Ankleshwar facility having won the gold award at the 9th Annual Conference on Quality Management organized by the American Society for Quality at Ahmedabad on 22nd November, 2019. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2487.30 -5.15 (-0.21%)
07-Jul-2026 14:54 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1903.95
Dr. Reddys Labs. 1355.90
Cipla 1456.60
Zydus Lifesciences 1154.40
Lupin 2487.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: